139 related articles for article (PubMed ID: 33544002)
1. TKP, a Serine Protease from
Zhao H; Song L
Nutr Cancer; 2022; 74(1):333-345. PubMed ID: 33544002
[TBL] [Abstract][Full Text] [Related]
2. TKP, a serine protease extracted from Trichosanthes kirilowii, inhibits the migration and invasion of colorectal adenocarcinoma cells by targeting Wnt/β-catenin and Hedgehog/Gli1 signalings.
Sun X; Xu X; Song L
Phytother Res; 2020 Apr; 34(4):867-878. PubMed ID: 31854039
[TBL] [Abstract][Full Text] [Related]
3. A serine protease extracted from Trichosanthes kirilowii induces apoptosis via the PI3K/AKT-mediated mitochondrial pathway in human colorectal adenocarcinoma cells.
Song L; Chang J; Li Z
Food Funct; 2016 Feb; 7(2):843-54. PubMed ID: 26673746
[TBL] [Abstract][Full Text] [Related]
4. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells.
Li R; Li P; Wang J; Liu J
Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299
[TBL] [Abstract][Full Text] [Related]
5. Serine/Arginine-Rich Splicing Factor 7 Knockdown Inhibits Aerobic Glycolysis and Growth in HepG2 Cells by Regulating PKM2 Expression.
Shi W; Yao X; Cao X; Fu Y; Wang Y
Curr Issues Mol Biol; 2024 May; 46(5):5023-5036. PubMed ID: 38785569
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity.
Fei M; Li X; Liang S; Zhou S; Wu H; Sun L; Liu Y; Hu Q; Liu L; Wang J
Cancer Lett; 2024 Mar; 584():216620. PubMed ID: 38218456
[TBL] [Abstract][Full Text] [Related]
7. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
[TBL] [Abstract][Full Text] [Related]
8. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
9. FOXA2 suppresses PKM2 transcription and affects the Wnt/β-catenin activity to block aerobic glycolysis in thyroid carcinoma.
He Y; Chen W; Yu L; Liu Y; Cheng Y; Li X; Yu G
Clin Exp Pharmacol Physiol; 2023 Jul; 50(7):561-572. PubMed ID: 36946190
[TBL] [Abstract][Full Text] [Related]
10. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
[TBL] [Abstract][Full Text] [Related]
11. miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
Hua S; Liu C; Liu L; Wu D
Biochem Biophys Res Commun; 2018 Feb; 496(3):947-954. PubMed ID: 29360449
[TBL] [Abstract][Full Text] [Related]
12. CaMKKβ regulates proliferation, apoptosis, and glycolysis of hepatocellular carcinoma via PI3K/AKT pathway.
Sheng T; Mao XB; Zhang SH
Ann Palliat Med; 2020 Nov; 9(6):3857-3869. PubMed ID: 33222471
[TBL] [Abstract][Full Text] [Related]
13. TFAIP6 facilitates hepatocellular carcinoma cell glycolysis through upregulating c-myc/PKM2 axis.
Duan K; Fang K; Sui C
Heliyon; 2024 May; 10(10):e30959. PubMed ID: 38813227
[TBL] [Abstract][Full Text] [Related]
14. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
[TBL] [Abstract][Full Text] [Related]
15. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
Zheng YL; Li L; Jia YX; Zhang BZ; Li JC; Zhu YH; Li MQ; He JZ; Zeng TT; Ban XJ; Yuan YF; Li Y; Guan XY
Theranostics; 2019; 9(3):796-810. PubMed ID: 30809309
[No Abstract] [Full Text] [Related]
16. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
17. NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase.
Gu Z; Xia J; Xu H; Frech I; Tricot G; Zhan F
J Hematol Oncol; 2017 Jan; 10(1):17. PubMed ID: 28086949
[TBL] [Abstract][Full Text] [Related]
18. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]